View in EDS

Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferase.

Saved in:
Bibliographic Details
Title: Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferase.
Authors: O' Donovan DH; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom. Electronic address: daniel.odonovan@astrazeneca.com., Gregson C; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Packer MJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Greenwood R; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Pike KG; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Kawatkar S; Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, United States., Bloecher A; Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, United States., Robinson J; Discovery Sciences R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Read J; Discovery Sciences R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Code E; Discovery Sciences R&D, 35 Gatehouse Drive, Waltham, MA 02451, United States., Hsu JH; Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, United States., Shen M; Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, United States., Woods H; Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, United States., Barton P; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Fillery S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Williamson B; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Rawlins PB; Discovery Sciences R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Bagal SK; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.
Source: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2021 May 01; Vol. 39, pp. 127904. Date of Electronic Publication: 2021 Mar 06.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1464-3405
DOI:10.1016/j.bmcl.2021.127904